MY Stock MarketDetailed Quotes

7081 PHARMA

Watchlist
  • 0.235
  • -0.005-2.08%
15min DelayMarket Closed Mar 28 16:58 CST
338.69MMarket Cap2.55P/E (TTM)

PHARMA Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating cash flow (direct method)
Cash income from operating activities
7.21%3.65B
16.35%1.04B
-6.10%884.53M
4.19%910.77M
17.31%812.5M
-4.02%3.4B
-15.53%894.83M
4.55%942M
14.35%874.14M
-15.68%692.59M
Revenue from customers
7.21%3.65B
16.35%1.04B
-6.10%884.53M
4.19%910.77M
17.31%812.5M
-4.02%3.4B
-15.53%894.83M
4.55%942M
14.35%874.14M
-15.68%692.59M
Cash paid
-7.01%-3.51B
-7.92%-904.53M
9.20%-862.78M
-19.27%-892.43M
-14.41%-846.77M
9.19%-3.28B
22.54%-838.13M
-11.47%-950.25M
15.39%-748.24M
6.27%-740.09M
Payments to suppliers for goods and services
-7.01%-3.51B
-7.92%-904.53M
9.20%-862.78M
-19.27%-892.43M
-14.41%-846.77M
9.19%-3.28B
22.54%-838.13M
-11.47%-950.25M
15.39%-748.24M
6.27%-740.09M
Direct dividend paid
Direct dividend received
Direct interest paid
-11.99%-68.11M
7.79%-14.62M
14.86%-13.76M
-52.38%-22.94M
-22.18%-16.78M
-47.29%-60.81M
-210.60%-15.86M
-14.65%-16.17M
-25.46%-15.06M
-36.23%-13.73M
Direct interest received
52.47%2.25M
27.10%394K
148.04%888K
256.16%520K
-32.13%450K
62.31%1.48M
30.25%310K
184.13%358K
-33.64%146K
103.37%663K
Direct tax refund paid
-64.81%-33.89M
-55.34%-15.18M
-175.65%-9.66M
-92.14%-4.25M
5.42%-4.8M
48.25%-20.56M
-281.01%-9.77M
68.16%-3.5M
84.00%-2.21M
58.85%-5.07M
Operating cash flow
-9.12%42.67M
241.60%107.18M
97.16%-783K
-107.66%-8.33M
15.61%-55.39M
132.99%46.95M
204.28%31.38M
-217.13%-27.56M
174.76%108.77M
-774.88%-65.64M
Investing cash flow
Net PPE purchase and sale
46.04%-31.08M
65.86%-11.85M
59.04%-6.03M
-6.26%-5.93M
-181.53%-7.27M
2.72%-57.6M
-105.15%-34.72M
-31.65%-14.72M
51.79%-5.58M
86.78%-2.58M
Net intangibles purchase and sale
18.61%-8.41M
12.63%-2.51M
57.91%-1.14M
-29.31%-3.47M
37.48%-1.3M
43.75%-10.34M
67.37%-2.87M
37.69%-2.71M
-21.14%-2.68M
31.35%-2.08M
Net investment product transactions
----
----
--618K
--40K
---6.54M
----
----
--0
--0
--0
Investing cash flow
41.87%-39.49M
77.44%-8.48M
62.41%-6.55M
-13.26%-9.35M
-224.23%-15.11M
6.08%-67.93M
-79.11%-37.59M
-16.25%-17.43M
39.89%-8.26M
79.40%-4.66M
Financing cash flow
Net issuance payments of debt
-4.39%18.67M
-128.51%-16.48M
117.70%10.45M
99.89%-143K
-70.48%24.84M
-93.72%19.52M
-33.58%57.81M
308.74%4.8M
-198.83%-127.23M
-13.71%84.14M
Net common stock issuance
--0
--0
----
----
----
--45.86M
--0
----
----
----
Increase or decrease of lease financing
33.62%-7.99M
38.48%-2.93M
17.30%-1.93M
34.77%-1.65M
38.59%-1.49M
-59.36%-12.04M
-18.10%-4.76M
-14.89%-2.33M
-149.90%-2.53M
-396.52%-2.42M
Cash dividends paid
----
----
----
----
----
90.48%-7.86M
--0
99.71%-30K
--30K
---7.86M
Cash dividends for minorities
-15.64%-244K
--0
---49K
----
----
-113.13%-211K
--0
--0
----
----
Net other fund-raising expenses
-76.65%11.67M
----
----
----
----
--50M
----
----
----
----
Financing cash flow
-76.80%22.1M
-107.51%-7.74M
-82.45%8.48M
98.47%-1.99M
-68.38%23.35M
-56.85%95.27M
34.77%103.05M
426.18%48.3M
-309.17%-129.94M
-23.87%73.86M
Net cash flow
Beginning cash position
141.14%127.44M
97.06%60.55M
117.00%60.27M
41.41%80.07M
141.14%127.44M
12.18%52.85M
9.47%30.73M
-19.78%27.77M
-56.86%56.62M
12.18%52.85M
Current changes in cash
-65.97%25.28M
-6.07%90.96M
-65.56%1.14M
33.13%-19.68M
-1,425.07%-47.15M
1,113.21%74.29M
281.38%96.84M
152.74%3.31M
69.70%-29.43M
-95.77%3.56M
Effect of exchange rate changes
-268.08%-516K
639.84%691K
-139.94%-859K
-120.55%-119K
-207.01%-229K
179.53%307K
79.12%-128K
-28.32%-358K
14.88%579K
10,600.00%214K
End cash Position
19.43%152.2M
19.43%152.2M
97.06%60.55M
117.00%60.27M
41.41%80.07M
141.14%127.44M
141.14%127.44M
9.47%30.73M
-19.78%27.77M
-56.86%56.62M
Free cash flow
111.59%3.1M
1,443.60%92.75M
82.40%-7.95M
-118.48%-17.74M
9.38%-63.96M
87.86%-26.71M
87.64%-6.9M
-666.48%-45.21M
160.26%95.98M
-449.70%-70.58M
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating cash flow (direct method)
Cash income from operating activities 7.21%3.65B16.35%1.04B-6.10%884.53M4.19%910.77M17.31%812.5M-4.02%3.4B-15.53%894.83M4.55%942M14.35%874.14M-15.68%692.59M
Revenue from customers 7.21%3.65B16.35%1.04B-6.10%884.53M4.19%910.77M17.31%812.5M-4.02%3.4B-15.53%894.83M4.55%942M14.35%874.14M-15.68%692.59M
Cash paid -7.01%-3.51B-7.92%-904.53M9.20%-862.78M-19.27%-892.43M-14.41%-846.77M9.19%-3.28B22.54%-838.13M-11.47%-950.25M15.39%-748.24M6.27%-740.09M
Payments to suppliers for goods and services -7.01%-3.51B-7.92%-904.53M9.20%-862.78M-19.27%-892.43M-14.41%-846.77M9.19%-3.28B22.54%-838.13M-11.47%-950.25M15.39%-748.24M6.27%-740.09M
Direct dividend paid
Direct dividend received
Direct interest paid -11.99%-68.11M7.79%-14.62M14.86%-13.76M-52.38%-22.94M-22.18%-16.78M-47.29%-60.81M-210.60%-15.86M-14.65%-16.17M-25.46%-15.06M-36.23%-13.73M
Direct interest received 52.47%2.25M27.10%394K148.04%888K256.16%520K-32.13%450K62.31%1.48M30.25%310K184.13%358K-33.64%146K103.37%663K
Direct tax refund paid -64.81%-33.89M-55.34%-15.18M-175.65%-9.66M-92.14%-4.25M5.42%-4.8M48.25%-20.56M-281.01%-9.77M68.16%-3.5M84.00%-2.21M58.85%-5.07M
Operating cash flow -9.12%42.67M241.60%107.18M97.16%-783K-107.66%-8.33M15.61%-55.39M132.99%46.95M204.28%31.38M-217.13%-27.56M174.76%108.77M-774.88%-65.64M
Investing cash flow
Net PPE purchase and sale 46.04%-31.08M65.86%-11.85M59.04%-6.03M-6.26%-5.93M-181.53%-7.27M2.72%-57.6M-105.15%-34.72M-31.65%-14.72M51.79%-5.58M86.78%-2.58M
Net intangibles purchase and sale 18.61%-8.41M12.63%-2.51M57.91%-1.14M-29.31%-3.47M37.48%-1.3M43.75%-10.34M67.37%-2.87M37.69%-2.71M-21.14%-2.68M31.35%-2.08M
Net investment product transactions ----------618K--40K---6.54M----------0--0--0
Investing cash flow 41.87%-39.49M77.44%-8.48M62.41%-6.55M-13.26%-9.35M-224.23%-15.11M6.08%-67.93M-79.11%-37.59M-16.25%-17.43M39.89%-8.26M79.40%-4.66M
Financing cash flow
Net issuance payments of debt -4.39%18.67M-128.51%-16.48M117.70%10.45M99.89%-143K-70.48%24.84M-93.72%19.52M-33.58%57.81M308.74%4.8M-198.83%-127.23M-13.71%84.14M
Net common stock issuance --0--0--------------45.86M--0------------
Increase or decrease of lease financing 33.62%-7.99M38.48%-2.93M17.30%-1.93M34.77%-1.65M38.59%-1.49M-59.36%-12.04M-18.10%-4.76M-14.89%-2.33M-149.90%-2.53M-396.52%-2.42M
Cash dividends paid --------------------90.48%-7.86M--099.71%-30K--30K---7.86M
Cash dividends for minorities -15.64%-244K--0---49K---------113.13%-211K--0--0--------
Net other fund-raising expenses -76.65%11.67M------------------50M----------------
Financing cash flow -76.80%22.1M-107.51%-7.74M-82.45%8.48M98.47%-1.99M-68.38%23.35M-56.85%95.27M34.77%103.05M426.18%48.3M-309.17%-129.94M-23.87%73.86M
Net cash flow
Beginning cash position 141.14%127.44M97.06%60.55M117.00%60.27M41.41%80.07M141.14%127.44M12.18%52.85M9.47%30.73M-19.78%27.77M-56.86%56.62M12.18%52.85M
Current changes in cash -65.97%25.28M-6.07%90.96M-65.56%1.14M33.13%-19.68M-1,425.07%-47.15M1,113.21%74.29M281.38%96.84M152.74%3.31M69.70%-29.43M-95.77%3.56M
Effect of exchange rate changes -268.08%-516K639.84%691K-139.94%-859K-120.55%-119K-207.01%-229K179.53%307K79.12%-128K-28.32%-358K14.88%579K10,600.00%214K
End cash Position 19.43%152.2M19.43%152.2M97.06%60.55M117.00%60.27M41.41%80.07M141.14%127.44M141.14%127.44M9.47%30.73M-19.78%27.77M-56.86%56.62M
Free cash flow 111.59%3.1M1,443.60%92.75M82.40%-7.95M-118.48%-17.74M9.38%-63.96M87.86%-26.71M87.64%-6.9M-666.48%-45.21M160.26%95.98M-449.70%-70.58M
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Newly Listed Companies in 2025 Newly Listed Companies in 2025

IPO Boom Continues! Bursa 2025 Listings Surge Nearly 100% on Debut! IPO Boom Continues! Bursa 2025 Listings Surge Nearly 100% on Debut!